Morgan Stanley’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2M Sell
107,812
-3,136
-3% -$481K ﹤0.01% 3094
2025
Q4
$15.2M Buy
110,948
+12,818
+13% +$1.66M ﹤0.01% 3184
2025
Q3
$11.9M Sell
98,130
-2,915
-3% -$314K ﹤0.01% 3385
2025
Q2
$10.8M Buy
101,045
+11,886
+13% +$1.19M ﹤0.01% 3365
2025
Q1
$8.27M Sell
89,159
-11,779
-12% -$1.14M ﹤0.01% 3515
2024
Q4
$10.9M Sell
100,938
-10,266
-9% -$1.25M ﹤0.01% 3330
2024
Q3
$14M Buy
111,204
+16,080
+17% +$2.02M ﹤0.01% 3149
2024
Q2
$10.3M Sell
95,124
-7,603
-7% -$741K ﹤0.01% 3299
2024
Q1
$9.71M Sell
102,727
-96,047
-48% -$9.09M ﹤0.01% 3371
2023
Q4
$18.4M Buy
198,774
+147,374
+287% +$11.3M ﹤0.01% 3422
2023
Q3
$3.29M Sell
51,400
-2,769
-5% -$177K ﹤0.01% 4037
2023
Q2
$3.35M Buy
54,169
+10,490
+24% +$622K ﹤0.01% 4063
2023
Q1
$2.54M Buy
43,679
+19,260
+79% +$1.11M ﹤0.01% 4304
2022
Q4
$1.45M Sell
24,419
-22,032
-47% -$1.34M ﹤0.01% 4656
2022
Q3
$2.94M Sell
46,451
-4,970
-10% -$345K ﹤0.01% 4143
2022
Q2
$3.59M Buy
51,421
+47,038
+1,073% +$3.29M ﹤0.01% 4053
2022
Q1
$307K Sell
4,383
-945
-18% -$63.6K ﹤0.01% 5679
2021
Q4
$361K Buy
5,328
+2,009
+61% +$139K ﹤0.01% 5741
2021
Q3
$232K Buy
3,319
+221
+7% +$16.1K ﹤0.01% 5917
2021
Q2
$216K Buy
3,098
+2,625
+555% +$191K ﹤0.01% 5972
2021
Q1
$36K Sell
473
-9,082
-95% -$643K ﹤0.01% 6503
2020
Q4
$634K Buy
9,555
+8,289
+655% +$546K ﹤0.01% 4929
2020
Q3
$79K Sell
1,266
-3,300
-72% -$206K ﹤0.01% 5534
2020
Q2
$289K Buy
4,566
+3,245
+246% +$218K ﹤0.01% 4895
2020
Q1
$94K Sell
1,321
-16,105
-92% -$1.27M ﹤0.01% 5211
2019
Q4
$1.51M Buy
17,426
+13,202
+313% +$1.1M ﹤0.01% 4244
2019
Q3
$346K Buy
4,224
+2,709
+179% +$224K ﹤0.01% 4860
2019
Q2
$123K Sell
1,515
-1,389
-48% -$107K ﹤0.01% 5228
2019
Q1
$220K Sell
2,904
-34,652
-92% -$2.75M ﹤0.01% 5008
2018
Q4
$2.95M Buy
37,556
+2,856
+8% +$224K ﹤0.01% 3447
2018
Q3
$2.62M Buy
34,700
+2,466
+8% +$181K ﹤0.01% 3789
2018
Q2
$2.27M Buy
32,234
+5,344
+20% +$350K ﹤0.01% 3950
2018
Q1
$1.6M Sell
26,890
-10,940
-29% -$671K ﹤0.01% 4200
2017
Q4
$2.31M Buy
37,830
+594
+2% +$37.9K ﹤0.01% 3911
2017
Q3
$2.33M Sell
37,236
-1,354
-4% -$87.2K ﹤0.01% 3729
2017
Q2
$2.71M Buy
38,590
+18,492
+92% +$1.32M ﹤0.01% 3503
2017
Q1
$1.43M Sell
20,098
-13,533
-40% -$1M ﹤0.01% 4101
2016
Q4
$2.55M Buy
33,631
+17,479
+108% +$1.21M ﹤0.01% 3705
2016
Q3
$1.07M Buy
16,152
+1,499
+10% +$97.3K ﹤0.01% 3986
2016
Q2
$949K Buy
14,653
+8,971
+158% +$570K ﹤0.01% 4008
2016
Q1
$354K Buy
5,682
+575
+11% +$35.8K ﹤0.01% 4634
2015
Q4
$314K Sell
5,107
-6,180
-55% -$400K ﹤0.01% 4844
2015
Q3
$687K Buy
11,287
+646
+6% +$40.4K ﹤0.01% 4396
2015
Q2
$692K Sell
10,641
-1,295
-11% -$82.2K ﹤0.01% 4479
2015
Q1
$761K Buy
11,936
+370
+3% +$23.5K ﹤0.01% 4337
2014
Q4
$726K Buy
11,566
+9,947
+614% +$598K ﹤0.01% 4398
2014
Q3
$90K Sell
1,619
-380
-19% -$21.5K ﹤0.01% 5518
2014
Q2
$113K Sell
1,999
-6,541
-77% -$356K ﹤0.01% 5443
2014
Q1
$476K Sell
8,540
-8,634
-50% -$452K ﹤0.01% 4596
2013
Q4
$926K Buy
17,174
+9,740
+131% +$498K ﹤0.01% 3991
2013
Q3
$351K Buy
+7,434
New +$355K ﹤0.01% 4572

Other funds holding NHC

Morgan Stanley's NHC Position: Q1 2026 in Review

Morgan Stanley reduced its National Healthcare (NHC) stake by 2.8% in Q1 2026, selling an estimated $481K and leaving 107,812 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3094.

Morgan Stanley first reported a position in NHC in Q3 2013 and has held it in 51 quarters since. The position peaked at $18.4M in Q4 2023. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Morgan Stanley held 107,812 shares of National Healthcare worth $17.2M as of Q1 2026.
  • Morgan Stanley sold 3,136 National Healthcare shares in Q1 2026, an estimated $481K.
  • National Healthcare made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3094 holding.
  • Morgan Stanley first reported a position in National Healthcare in Q3 2013 and has held it in 51 quarters since.
  • Morgan Stanley's National Healthcare position peaked at $18.4M in Q4 2023.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.